[Do tendon lesions occur during quinolone administration?].
Shah
P
P
Medizinische Klinik III, Universitätsklinikum, Frankfurt.
D000125:Achilles Tendon / Q000187:drug effects* / Q000293:injuries*; D000328:Adult; D000367:Age Factors; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001991:Bronchitis / Q000188:drug therapy; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D024841:Fluoroquinolones / Q000008:administration & dosage*; D006801:Humans; D015994:Incidence; D008297:Male; D009643:Norfloxacin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D015242:Ofloxacin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D012307:Risk Factors; D012421:Rupture; D013997:Time Factors
D000890:Anti-Infective Agents; D004791:Enzyme Inhibitors; D024841:Fluoroquinolones; D002939:Ciprofloxacin; D015242:Ofloxacin; D009643:Norfloxacin